{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:52:34Z","timestamp":1790211154149,"version":"4.1.0"},"reference-count":62,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1080\/10428190310001602363","type":"journal-article","created":{"date-parts":[[2003,12,30]],"date-time":"2003-12-30T16:59:00Z","timestamp":1072803540000},"page":"433-440","source":"Crossref","is-referenced-by-count":73,"title":["Evolution Of Clonal Cytogenetic Abnormalities in Aplastic Anemia"],"prefix":"10.1080","volume":"45","author":[{"given":"Jaroslaw P","family":"Maciejewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Selleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"CIT0001","first-page":"534\u2014 546","volume":"136","author":"Young N.S","year":"2002","journal-title":"\"Acquired aplastic anemia\", Annals Internal Medicine"},{"key":"CIT0002","first-page":"1015","volume":"115","author":"Maciejewski J.P.","year":"2001","journal-title":"\"Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-defi-cient clones\", British Journal of Haematology"},{"key":"CIT0003","first-page":"401 \u2014408","volume":"131","author":"Dunn D.E.","year":"1999","journal-title":"\"Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes\", Annals Internal Medicine"},{"key":"CIT0004","first-page":"1134","volume":"15","author":"Appelbaum F.R.","year":"1987","journal-title":"\"Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia\", Experimental Hematology"},{"key":"CIT0005","first-page":"256","volume":"49","author":"Varma N.","year":"1995","journal-title":"\"Unusual clonal cytogenetic abnormalities in aplastic anemia\", American Journal of Hematology"},{"key":"CIT0006","first-page":"699","volume":"99","author":"Molldrem, ii., Caples, M., Mavroudis, D., Plante, M., Young, N.S., Barrett, A.J., et al.","year":"1997","journal-title":"\"Antithymocyte globulin for patients with myelodysplastic syndrome\", British Journal of Haematology"},{"key":"CIT0007","first-page":"156 \u2014 163","volume":"137","author":"Molldrem, Li., Leifer, E., Bahceci, E., Saunthararajah, Y., Rivera, M., Dunbar, C., et al.","year":"2002","journal-title":"\"Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes\", Annals Internal Medicine"},{"key":"CIT0008","first-page":"1911","volume":"95","author":"Selleri C.","year":"2002","journal-title":"in vitro and in vivo studies\", Cancer"},{"key":"CIT0009","first-page":"103, 297\u2014 303","author":"Kaito K.","year":"1998","journal-title":"British Journal of Haematology"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.1997.0138"},{"key":"CIT0011","first-page":"152 \u2014 158","volume":"77","author":"Bessho M.","year":"2003","journal-title":"\"Multicenter prospective study of clonal complications in adult aplastic anemia patients following recombi-nant human granulocyte colony-stimulating factor (lenograstim) administration\", International Journal of Hematology"},{"key":"CIT0012","first-page":"2049","volume":"96","author":"Kojima S.","year":"2000","journal-title":"\"Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia\", Blood"},{"key":"CIT0013","first-page":"69","volume":"37","author":"Bacigalupo A.","year":"2000","journal-title":"bone marrow transplantation compared with immunosup-pressive therapy\u2014The European Group for Blood and Marrow Transplantation experience\", Seminars in Hematology"},{"key":"CIT0014","first-page":"3129","volume":"99","author":"Maciejewski J.P.","year":"2002","journal-title":"\"Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia\", Blood"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3513"},{"key":"CIT0016","first-page":"100, 1 \u2014 6","author":"Sloand EM.","year":"2002","journal-title":"Blood"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10428199909058423","author":"Tooze JA.","year":"1999","journal-title":"Leukemia and Lymphoma"},{"key":"CIT0019","first-page":"322\u2014 330","volume":"28","author":"Miescher PA.","year":"1991","journal-title":"\"Autoimmune myelodysplasias\", Seminars in Hematology"},{"key":"CIT0020","first-page":"283","volume":"85","author":"Paquette R.L.","year":"1991","journal-title":"comparison with bone marrow transplantation\", Blood"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb02434.x"},{"key":"CIT0022","first-page":"189","volume":"75","author":"Jameel T.","year":"1997","journal-title":"\"Aplastic anemia or aplastic preleukemic syndrome?\", Annals of Hematology"},{"key":"CIT0024","first-page":"107","volume":"126","author":"Doney K.","year":"1997","journal-title":"Seattle Bone Marrow Transplant Team\", Annals of Internal Medicine"},{"key":"CIT0025","first-page":"121","volume":"73","author":"de Planque MM.","year":"1989","journal-title":"Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT)\", British Journal of Haematology"},{"key":"CIT0026","first-page":"329, 1152 \u2014 115","author":"Socie G","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"CIT0027","first-page":"91","volume":"37","author":"Socie G.","year":"2000","journal-title":"\"Late clonal diseases of treated aplastic anemia\", Seminars in Hematology"},{"key":"CIT0028","first-page":"1823","volume":"189","author":"McHeyzer-Williams L.J.","year":"1999","journal-title":"preimmune and antigen-driven selection of preferred complementarity-determining region 3 (CDR3) motifs\", Journal of Experimental Medicine"},{"key":"CIT0029","first-page":"167 \u2014 171","volume":"66","author":"Keung Y.K.","year":"2001","journal-title":"\"Bone marrow cytogenetic abnormalities of aplastic anemia\", American Journal of Hematology"},{"key":"CIT0030","first-page":"313 \u2014 319","volume":"118","author":"Ohga S.","year":"2002","journal-title":"\"Treatment responses of childhood aplastic anaemia with chromosomal aberrations at diagnosis\", British Journal of Haematology"},{"key":"CIT0031","first-page":"271 \u2014 274","volume":"104","author":"Geary C.G.","year":"1999","journal-title":"response to immunosuppressive therapy\", British Journal of Haematology"},{"key":"CIT0032","first-page":"418 \u2014422","volume":"81","author":"Mikhailova N.","year":"1996","journal-title":"\"Cytogenetic abnormalities in patients with severe aplastic anemia\", Haematologica"},{"key":"CIT0033","first-page":"1931 \u2014 1934","volume":"95","author":"Bacigalupo A.","year":"2000","journal-title":"European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO)\", Blood"},{"key":"CIT0034","first-page":"1236","volume":"101","author":"Frickhofen N.","year":"2003","journal-title":"11-year follow-up of a randomized trial comparing treatments of aplastic anemia\", Blood"},{"key":"CIT0035","first-page":"173\u2014 179","volume":"210","author":"Fuhrer M.","year":"1998","journal-title":"German\/Austrian Pediatric Aplastic Anemia Working Group\", Klin Padiatric"},{"key":"CIT0036","first-page":"151","volume":"116","author":"Ohara A.","year":"2002","journal-title":"\"Evolution of myelodysplastic syndrome and acute myelogenous leukaemia in children with hepatitis-associated aplas-tic anaemia\", British Journal of Haematology"},{"key":"CIT0037","first-page":"747","volume":"117","author":"Ishiyama K.","year":"2002","journal-title":"a benign subset of bone marrow failure responsive to immunosuppressive therapy\", British Journal of Haematology"},{"key":"CIT0038","first-page":"477","volume":"135","author":"Brodsky R.A.","year":"2001","journal-title":"\"Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia\", Annals Internal of Medicine"},{"key":"CIT0039","first-page":"4668","volume":"100","author":"Tisdale J.F.","year":"2002","journal-title":"follow-up of a randomized trial\", Blood"},{"key":"CIT0040","first-page":"786\u2014 790","volume":"100","author":"Kojima S.","year":"2002","journal-title":"\"Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children\", Blood"},{"key":"CIT0041","first-page":"1130","volume":"289","author":"Rosenfeld S.","year":"2003","journal-title":"association between hematologic response and long-term outcome\", JAMA"},{"key":"CIT0042","first-page":"166A","volume":"100","author":"Sloand E.","year":"2002","journal-title":"Blood"},{"key":"CIT0043","first-page":"133 \u2014 144","volume":"13","author":"Michalova K.","year":"1990","journal-title":"The Czechoslovak MDS Cooperative Group\", Czech Medicine"},{"key":"CIT0044","first-page":"108, 346\u2014 356","author":"Sole F.","year":"2000","journal-title":"British Journal of Haematology"},{"key":"CIT0046","first-page":"270","volume":"46","author":"Bernasconi P.","year":"1994","journal-title":"relations to morphology, clinical evolution, and survival\", American Journal of Hematology"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)60566-7"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(90)90193-E"},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"1983\u2013","DOI":"10.1182\/blood.V88.6.1983.bloodjournal8861983","volume":"88","author":"Maciejewslci J.P.","year":"1991","journal-title":"Blood"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199712)56:4<224::AID-AJH5>3.0.CO;2-Z"},{"key":"CIT0051","first-page":"2245","author":"Kennedy B.","year":"1997","journal-title":"Blood"},{"key":"CIT0052","first-page":"4075 \u2014 4083","volume":"96","author":"Slovak M.L.","year":"2000","journal-title":"a Southwest Oncology Group\/ Eastern Cooperative Oncology Group Study\", Blood"},{"key":"CIT0053","first-page":"2322 \u2014 2333","volume":"92","author":"Grimwade D.","year":"1998","journal-title":"The Medical Research Council Adult and Children's Leukaemia Working Parties\", Blood"},{"key":"CIT0054","first-page":"2079 \u2014 2088","volume":"89","author":"Greenberg P.","year":"1997","journal-title":"\"International scoring system for evaluating prognosis in myelodysplastic syndromes\", Blood"},{"key":"CIT0055","first-page":"839","volume":"24","author":"de Souza FT.","year":"1997","journal-title":"\"Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leuke-mia\", Leukemia Research"},{"key":"CIT0056","first-page":"21\u2014 24","volume":"82","author":"Elghetany MT.","year":"1997","journal-title":"an additional tool for differential diagnosis\", Haematologica"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05356.x"},{"key":"CIT0058","first-page":"357","volume":"23","author":"Goyal R.","year":"1999","journal-title":"\"Biologic characteristics of patients with hypocellular myelodysplastic syndromes\", Leukemia Research"},{"key":"CIT0059","first-page":"153 \u2014 163","volume":"54","author":"Riccardi A.","year":"1987","journal-title":"clinical course according to bone marrow cytology and cellularity\", Blut"},{"key":"CIT0060","first-page":"304\u2014 309","volume":"100","author":"Jonasova A.","year":"1998","journal-title":"\"Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow\", British Journal of Haematology"},{"key":"CIT0061","first-page":"133\u2014 138","volume":"85","author":"Catalano L.","year":"2000","journal-title":"\"Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies\", Haematologica"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04136.x"},{"key":"CIT0063","first-page":"2156","volume":"101","author":"Steensma D.P.","year":"2003","journal-title":"\"Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodys-plastic syndrome\", Blood"},{"key":"CIT0064","first-page":"100, 1570 \u20141574","author":"Saunthararajah Y.","year":"2000","journal-title":"Blood"},{"key":"CIT0065","first-page":"786\u2014 790","volume":"100","author":"Kojima S.","year":"2002","journal-title":"\"Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children\", Blood"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428190310001602363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T12:59:59Z","timestamp":1585400399000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428190310001602363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,8,3]]},"published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1080\/10428190310001602363"],"URL":"https:\/\/doi.org\/10.1080\/10428190310001602363","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}